{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T12:40:18Z","timestamp":1683549618396},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"DOI":"10.1093\/ndt\/gfl431","type":"journal-article","created":{"date-parts":[[2006,8,6]],"date-time":"2006-08-06T00:24:01Z","timestamp":1154823841000},"page":"2736-2744","source":"Crossref","is-referenced-by-count":2,"title":["TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats"],"prefix":"10.1093","volume":"21","author":[{"given":"Junya","family":"Yamahana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Furuichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,8,5]]},"reference":[{"key":"key\n\t\t\t\t20171012190828_B1","doi-asserted-by":"crossref","unstructured":"Davidson A and Diamond B. (2001) Autoimmune diseases. N Engl J Med345:340\u2013350.","DOI":"10.1056\/NEJM200108023450506"},{"key":"key\n\t\t\t\t20171012190828_B2","doi-asserted-by":"crossref","unstructured":"Wada T, Matsushima K, Yokoyama H. (2003) Chemokines as the therapeutic targets for renal diseases. Curr Med Chem Anti-inflammatory & Anti-allergy Agents2:175\u2013190.","DOI":"10.2174\/1568014033483824"},{"key":"key\n\t\t\t\t20171012190828_B3","doi-asserted-by":"crossref","unstructured":"Wada T, Yokoyama H, Furuichi K, et al. (1996) Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF\/MCP-1). FASEB J10:1418\u20131425.","DOI":"10.1096\/fasebj.10.12.8903512"},{"key":"key\n\t\t\t\t20171012190828_B4","doi-asserted-by":"crossref","unstructured":"Lu Y, Sakamaki S, Kuroda H, et al. (2001) Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603. Blood97:1123\u20131130.","DOI":"10.1182\/blood.V97.4.1123"},{"key":"key\n\t\t\t\t20171012190828_B5","doi-asserted-by":"crossref","unstructured":"Ohta Y, Yamane M, Sohda T, Makino H. (1997) TAK-603 selectively suppresses Th1-type cytokine production and inhibits the progression of adjuvant arthritis. Immunology92:75\u201383.","DOI":"10.1046\/j.1365-2567.1997.d01-2288.x"},{"key":"key\n\t\t\t\t20171012190828_B6","doi-asserted-by":"crossref","unstructured":"Fujita T, Ezoe K, Matsumoto Y, et al. (2002) TAK-603, new rheumatic drug, inhibits rat mixed lymphocyte reactions and prolongs rat skin allograft survival. Transplant Proc34:1133\u20131135.","DOI":"10.1016\/S0041-1345(02)02810-5"},{"key":"key\n\t\t\t\t20171012190828_B7","unstructured":"Krakower CA and Greenspon SA. (1951) Localization of nephrotoxic antigen within the isolated renal glomerus. AMA Arch Pathol51:629\u2013639."},{"key":"key\n\t\t\t\t20171012190828_B8","doi-asserted-by":"crossref","unstructured":"Wada T, Schwarting A, Kinoshita K, et al. (1999) Fas on renal parenchymal cells does not promote autoimmune nephritis in MRL mice. Kidney Int55:841\u2013851.","DOI":"10.1046\/j.1523-1755.1999.055003841.x"},{"key":"key\n\t\t\t\t20171012190828_B9","doi-asserted-by":"crossref","unstructured":"Ikezumi Y, Kanno K, Koike H, et al. (2002) FK506 ameliorates proteinuria and glomerular lesions induced by anti-Thy 1.1 monoclonal antibody 1-22-3. Kidney Int61:1339\u20131350.","DOI":"10.1046\/j.1523-1755.2002.00259.x"},{"key":"key\n\t\t\t\t20171012190828_B10","doi-asserted-by":"crossref","unstructured":"Yan Y, Putten K, Bowen D, et al. (2002) Postoperative administration of donor B cells induces rat kidney allograft acceptance: lack of association with Th2 cytokine expression in long-term accepted grafts. Transplantation73:1123\u20131130.","DOI":"10.1097\/00007890-200204150-00020"},{"key":"key\n\t\t\t\t20171012190828_B11","doi-asserted-by":"crossref","unstructured":"Tipping PG, Kiching AR, Huang XR, Mutch DA, Holdsworth SR. (1997) Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol27:530\u2013537.","DOI":"10.1002\/eji.1830270226"},{"key":"key\n\t\t\t\t20171012190828_B12","doi-asserted-by":"crossref","unstructured":"Kitching AR, Tipping PG, Timoshanko JR, Holdworth SR. (2000) Endogeneous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis. Kidney Int57:518\u2013525.","DOI":"10.1046\/j.1523-1755.2000.00872.x"},{"key":"key\n\t\t\t\t20171012190828_B13","doi-asserted-by":"crossref","unstructured":"Wada T, Furuichi K, Sakai N, et al. (2001) Involvement of p38 mitogen-activated protein kinase followed by chemokine expression in crescentic glomerulonephritis. Am J Kidney Dis38:1169\u20131177.","DOI":"10.1053\/ajkd.2001.29206"},{"key":"key\n\t\t\t\t20171012190828_B14","doi-asserted-by":"crossref","unstructured":"Wada T, Furuichi K, Sakai N, et al. (2000) A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats. J Am Soc Nephrol11:1534\u20131541.","DOI":"10.1681\/ASN.V1181534"},{"key":"key\n\t\t\t\t20171012190828_B15","unstructured":"Abe T, Kida H, Yoshimura M, et al. (1986) Participation of extracapillary lesions (ECL) in progression of IgA nephropathy. Clin Nephrol25:37\u201341."},{"key":"key\n\t\t\t\t20171012190828_B16","doi-asserted-by":"crossref","unstructured":"Del Prete G. (1998) The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int Rev Immunol16:427\u2013455.","DOI":"10.3109\/08830189809043004"},{"key":"key\n\t\t\t\t20171012190828_B17","doi-asserted-by":"crossref","unstructured":"Wangoo A, Sparer T, Brown IN, et al. (2001) Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease. J Immunol166:3432\u20133439.","DOI":"10.4049\/jimmunol.166.5.3432"},{"key":"key\n\t\t\t\t20171012190828_B18","doi-asserted-by":"crossref","unstructured":"Sempowski GD, Derdak S, Phipps RP. (1996) Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol167:290\u2013296.","DOI":"10.1002\/(SICI)1097-4652(199605)167:2<290::AID-JCP13>3.0.CO;2-C"},{"key":"key\n\t\t\t\t20171012190828_B19","doi-asserted-by":"crossref","unstructured":"Lee SK, Park JY, Chung SJ, et al. (1998) Chemokines, osteopontin, ICAM-1 gene expression in cultured rat mesangial cells. J Korean Med Sci13:165\u2013170.","DOI":"10.3346\/jkms.1998.13.2.165"},{"key":"key\n\t\t\t\t20171012190828_B20","doi-asserted-by":"crossref","unstructured":"Schwarz M, Radeke HH, Resch K, Uciechowski P. (1997) Lymphocyte-derived cytokines induce sequential expression of monocyte- and T cell-specific chemokines in human mesangial cells. Kidney Int52:1521\u20131531.","DOI":"10.1038\/ki.1997.482"},{"key":"key\n\t\t\t\t20171012190828_B21","doi-asserted-by":"crossref","unstructured":"Wada T, Furuichi K, Segawa-Takaeda C, et al. (1999) MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int56:995\u20131003.","DOI":"10.1046\/j.1523-1755.1999.00646.x"},{"key":"key\n\t\t\t\t20171012190828_B22","doi-asserted-by":"crossref","unstructured":"Furuichi K, Wada T, Sakai N, et al. (2000) Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Am J Nephrol20:291\u2013299.","DOI":"10.1159\/000013603"},{"key":"key\n\t\t\t\t20171012190828_B23","doi-asserted-by":"crossref","unstructured":"Kitagawa K, Wada T, Furuichi K, et al. (2004) Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol165:237\u2013246.","DOI":"10.1016\/S0002-9440(10)63292-0"},{"key":"key\n\t\t\t\t20171012190828_B24","doi-asserted-by":"crossref","unstructured":"Remuzzi G and Bertani T. (1998) Pathophysiology of progressive nephropathies. N Engl J Med339:1448\u20131456.","DOI":"10.1056\/NEJM199811123392007"},{"key":"key\n\t\t\t\t20171012190828_B25","doi-asserted-by":"crossref","unstructured":"Huang XR, Tipping PG, Shuo L, Holdworth SR. (1997) Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int51:94\u2013103.","DOI":"10.1038\/ki.1997.12"},{"key":"key\n\t\t\t\t20171012190828_B26","unstructured":"Tagawa Y, Kiyota Y, Yoshimura Y, Motohashi M, Tanayama S. (1998) Disposition of the new antirheumatic agent ethyl 4-(3, 4-dimethoxyphenyl)-6, 7-dimethoxy-2-(1, 2, 4-triazol-1-ylmethyl)-quinoline-3-carboxylate (TAK-603) in rats and dogs. Arzneimittelforschung48:750\u2013757."},{"key":"key\n\t\t\t\t20171012190828_B27","doi-asserted-by":"crossref","unstructured":"Fujinaka H, Yamamoto T, Feng L, et al. (1997) Crucial role of CD8-positive lymphocytes in glomerular expression of ICAM-1 and cytokines in crescentic glomerulonephritis of WKY rats. J Immunol158:4978\u20134983.","DOI":"10.4049\/jimmunol.158.10.4978"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/10\/2736\/7625194\/gfl431.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T12:06:18Z","timestamp":1683547578000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/10\/2736\/1865869\/TAK603-an-antiinflammatory-compound-reduces"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,5]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2006,8,5]]},"published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfl431","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,10]]},"published":{"date-parts":[[2006,8,5]]}}}